Susan Hasty, Publisher
Table of Contents . . . November 10th, 1997Non-Subscriber - Summaries Only
Cancer Gene Therapy - Phase I-II Trial of Adv-Mediated IL-2 Adenocarcinoma Gene Therapy Initiated
Cancer Gene Therapy - Doctors Take Aim at Cancer With Magic Bullet
Chronic Granulomatous Disease - Study Advances Development of Gene Therapy for CGD
Conference Coverage (ICAAC) - Search For Elusive Genital Herpes Vaccine Continues
Dental Health - NIDR Supports Total Genome Studies of Major Oral Pathogens
Diabetes - Tiny Worms Hold Vital Clues for Treatment
Industry News (Joint Venture) - Chinese Government Contract Awarded to Sequence Liver Cancer Gene
Inflammatory Disease - New Form Of Gene Therapy Holds Promise For The Future
Melanoma Vaccine (Clinical Trial) - Phase I Trial of Autologous Melanoma Vaccine Terminated
Nephronophithisis 1 (NPH1) - Gene Responsible for Hereditary Adolescent Kidney Disease Identified
Parkinson's Disease - Avigen Demonstrates Gene Therapy Success in Treating Animal Model of Disease
Renal Cell Carinoma - Hybrid Cell Vaccine Used to Treat Patients
Transplantation (Cornea) - Lab Cultures May Usher in New Era for Corneal Transplants
Vaccine Development - Studies Show Vaccine Technology Identifies Disease-Specific Epitopes
Vectors (Development) - HIV-Based Vector Sustains Efficient Gene Transfer into the Retina
Vectors (Development) - Plasmovirus Combines Viral and Nonviral Methods of Gene Transfer
Cancer Gene Therapy - "Telomerase Inhibition by Inducible Expression of Antisense RNA."
Genetics (Parasites) - "A Biochemical and Genetic Model for Parasite Antifolate Resistance."
Antisense Technology - "Making (Anti)sense of Non-Coding Sequence Conservation."
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.